project id: TCGA-PRAD; case submitter id: TCGA-CH-5790; selected normal wgs: true; state: released; spectrophotometer method: UV Spec; age at index: 64; days to birth: -23529; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 23529; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic t: T2c; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 974.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 3; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 4; site of resection or biopsy: Prostate gland; synchronous malignancy: Not Reported; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 32.0; intermediate dimension: 0.4; longest dimension: 1.0; preservation method: Unknown; shortest dimension: 0.3; sample id: 5c8782c0-0b0d-4aff-b996-423d214ff5ff; sample submitter id: TCGA-CH-5790-01A; portion id: 410f5e4a-65ae-4c1c-8439-c6272dc7de50; portion submitter id: TCGA-CH-5790-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent stromal cells: 15.0;